Opioid Use Disorder: Identifying Patients At Risk and Developing Management Plans

Faculty

Johnathan H. Goree, MD
Service Line Director - Neurosciences
Director of Chronic Pain Division
Associate Professor of Anesthesiology University of Arkansas for Medical Sciences (UAMS)
Little Rock, AR
Melissa J. Durham, PharmD, MACM
Associate Professor of Clinical Pharmacy
USC Mann School of Pharmacy and Pharmaceutical Sciences
Clinical Pharmacist, The USC Pain Center
Los Angeles, CA
Melissa J. Durham, PharmD, MACM

Melissa J. Durham is an Associate Professor of Clinical Pharmacy and an Associate Dean at the University of Southern California (USC) Mann School of Pharmacy and Pharmaceutical Sciences.  Dr. Durham received her Doctor of Pharmacy degree, completed a residency in Community-based Pharmacy Practice, and has a Master of Academic Medicine degree, all from USC. She has been a clinical pharmacist at the USC Pain Center since 2008, where she runs a pharmacist-led pain medication management service for patients with a variety of complicated chronic, nononcologic pain conditions. She is dedicated to improving the quality of life for people with chronic pain through patient-centered and compassionate care. The value of her unique practice model has been recognized and published both nationally and internationally. Dr. Durham is also a practicing community pharmacist and provides a valuable and unique perspective of a clinician who is both a prescriber and a dispenser.

Statement of Need

Patients and health care professionals (HCPs) face additional challenges when the treatments prescribed for pain management (e.g., opioids) lead to substance use problems. HCPs must then re-evaluate treatment plans for acute, subacute, and chronic pain and encourage treatment for opioid use disorder (OUD). There are strategies available to HCPs to help identify patients at risk for OUD, most notably found in the 2022 CDC Guideline for Prescribing Opioids, which could help prevent OUD in patients through screening and identifying alternate treatments. For those patients who may present with concern for OUD, HCPs should be able to apply Diagnostic Statistical Manual of Mental Disorders’ (DSM)-5 criteria to properly diagnose OUD and work with patients to initiate effective treatment plans for OUD.

An interactive infographic from CME Outfitters entitled, Opioid Use Disorder: Identifying Patients At Risk and Developing Management Plans, consisting of three “escape-room” style activities, will be presented to show learners tools to identify patients at risk for OUD, diagnose patients with OUD, and develop treatment plans for the underlying pain as well as the subsequent OUD. The four three rooms will model practice environments with challenges designed by a team of expert, interdisciplinary faculty that cover strategies from the 2022 CDC Guideline for Prescribing Opioids for screening and identifying patients at risk for OUD, as well as ways to diagnose and treat OUD.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Incorporate strategies from the 2022 CDC Guideline for Prescribing Opioids into the development of safe and effective pain management plans for patients with acute, subacute, and chronic pain
  • Apply the DSM-5 criteria to identify and diagnose OUD in patients prescribed opioids for acute and chronic pain
  • Develop strategies for engaging patients in treatment for OUD

 

Financial Support

This activity is supported by an independent educational grant from Opioid Analgesic REMS Program Companies.

Target Audience

Physicians, dentists, physician associates (PAs), nurse practitioners (NPs), nurses, psychologists, and optometrists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 1.0

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.0

This activity is designated for 1.00 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.00 contact hours ( 0.1 CEUs) of continuing pharmacy credit ( JA0007185-0000-23-098-H01-P ).

PAs (AAPA) 1.00

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 02/01/2025. PAs should only claim credit commensurate with the extent of their participation.

Optometry (COPE) 1.0

This course is COPE approved for 1.00 hours of CE credit. Course #: 89448-PB Activity #: 127663

Psychologists (APA) 1.0

Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.

Dentists (ADA CERP) 1.0

CME Outfitters, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP. CME Outfitters, LLC designates this activity for 1.00 continuing education credits. Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Family Physicians (AAFP) 1.0

The AAFP has reviewed this activity and deemed it acceptable for up to 1.00 Enduring Material AAFP Prescribed credits. Term of approval is from 02/01/2024 to 02/01/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

Disclosure Declaration

Dr. Goree reports the following financial relationships:

Consultant: Abbott; Saluda Medical; and Stratus Medical, LLC
Research Support: Mainstay Medical (to UAMS) and SPR Therapeutics (to UAMS)

Dr. Durham reports no financial relationships to disclose.

The following individuals have no financial relationships to disclose: 

Marlon (Tony) Graham, MD (Peer Reviewer)
Joshua Caballero, PharmD, BCPP, FCCP (Peer Reviewer)
Mary Gleason, PhD (Planning Committee)
Kellie Busby, PharmD, BCPP (Planning Committee)
Kasey Brandt, PharmD (Planning Committee)
Susan H. Yarbrough, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

IN-006-020124-62

Opioid Use Disorder: Identifying Patients At Risk and Developing Management Plans
Event Date: 02/01/2024